FDA draft guidance on compounding and repackaging

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2015年 / 1540卷 / 1期

关键词：

D O I：

10.1007/s40278-015-7850-y

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：2 / 2

相关论文

共 50 条

[21] FDA draft guidance and health-outcomes research
Revicki, Dennis A.
LANCET, 2007, 369 (9561): : 540 - 542
[22] FDA Releases New Draft Guidance on Compounded Drugs
不详
JOURNAL OF NUCLEAR MEDICINE, 2019, 60 (02) : 8N - 8N
[23] US FDA publishes draft guidance on clinical pharmacogenomics
不详
BIOANALYSIS, 2011, 3 (07) : 720 - 720
[24] New FDA xenotransplantation documents: a proposed rule and a draft guidance
Bloom, ET
XENOTRANSPLANTATION, 2001, 8 (03) : 153 - 154
[25] FDA Releases Draft Guidance on Regulation of Genetically Engineered Animals
Gluck, John P.
Holdsworth, Mark T.
KENNEDY INSTITUTE OF ETHICS JOURNAL, 2008, 18 (04) : 393 - 402
[26] Meeting on the FDA draft guidance on patient-reported outcomes
Dueck, Amylou C.
Sloan, Jeff A.
VALUE IN HEALTH, 2007, 10 : S64 - S65
[27] US FDA issues draft guidance on shared REMS for generics
Reactions Weekly, 2017, 1679 (1) : 3 - 3
[28] Introduction to Discussion Papers on Draft FDA Guidance on Adaptive Designs
Chang, Mark
JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2010, 20 (06) : 1113 - 1114
[29] US FDA issues draft guidance on currently unapproved medicines
Reactions Weekly, 2003, 974 (1) : 3 - 3
[30] Interchangeability Of Biological Drug Products-FDA Draft Guidance
Endrenyi, Laszlo
Markus, Richard
JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2019, 29 (06) : 1003 - 1010

← 1 2 3 4 5 →